CVS Health (CVS) earnings in Q1 2021 beat – fr

0
12
CVS Health (CVS) earnings in Q1 2021 beat – fr


CVS Health reported a strong first quarter on Tuesday and raised its guidance for the full year, as customers walked to its stores for Covid-19 vaccinations, tests and prescriptions.
The company has been a major supplier of Covid-19 vaccines and has recently started offering same-day appointments for vaccines.

The company’s shares rose nearly 2% in pre-market trading.

Here’s what the company reported for the fiscal first quarter ended March 31, compared to what analysts expected, based on an analyst survey by Refinitiv:

  • Adjusted earnings per share: $ 2.04 vs. $ 1.72 expected
  • Turnover: $ 69.1 billion against $ 68.39 billion expected

The healthcare company and drugstore chain reported net income of $ 2.22 billion, or $ 1.68 per share, compared to $ 2.01 billion, or $ 1.53 per share, a year earlier.

Excluding items, it gained $ 2.04 per share, more than the $ 1.72 per share expected by analysts polled by Refinitiv.

Revenue rose to $ 69.1 billion from $ 66.8 billion a year earlier. This exceeded analysts’ expectations of $ 68.39 billion.

The company has raised its forecast for the year. He said he expects 2021 earnings to vary between $ 6.24 and $ 6.36 per share, and after adjustments between $ 7.56 and $ 7.68 per share.

He recalled that its cash flow from operations for the full year is expected to range from $ 12 billion to $ 12.5 billion.

The drugstore chain faced difficult year-over-year comparisons during the quarter in its retail business. In the period a year earlier, customers rushed to fill prescriptions early and stock up on other health and personal care items before shelter-in-place orders. Virtual tours and prescription home deliveries have increased – and customers have thrown more front-of-store items, such as soap and shampoo, into their in-store and online baskets.

CVS said on Tuesday it saw lower in-store sales in the first quarter of this year due to accelerating demand in March 2020 and a weak cough, cold and flu season.

Comparable store sales across its pharmacy and front-end store were up just 0.4%, compared to growth of 9% a year earlier. The front store’s same-store sales declined 11.4%.

However, he said his income was increased thanks to Covid-19 tests and vaccinations. CVS fired in its stores and long-term care facilities. He said the prescriptions filled were about the same as a year earlier on a 30-day equivalent basis.

As of Monday’s close, shares of CVS were up nearly 14% this year. They closed at $ 77.69 on Monday, bringing the market value of the company to $ 101.97 billion.

Read the full version here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here